|
NYMXF Nymox Pharmaceutical Corp 1018735 |
| Income Statement |
|
Net Income
|
2024-12-31
|
$-4,492,000.00 |
| Balance Sheet |
|
Current Assets
|
$653,000.00 |
|
Assets
|
$654,000.00 |
|
Current Liabilities
|
$7,429,000.00 |
|
Liabilities
|
$7,429,000.00 |
|
Equity
|
$-6,775,000.00 |
|
Shares Out
|
94540140.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,601,000.00 |
| Market Analysis |
Market Cap
|
$1,890,802.80 |
|
Price
|
$0.02 |
|
PB
|
5.48 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:45 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NYMXF documents filed with the SEC.
NYMXF Filings
Clear
